It is perhaps relevant that GABA can function as a co-transmitter in monoaminergic neurons and its release is dependent on Vmat2; thus some of the phenotypes in vmat2 mutants may reflect altered GABAergic signalling and may interact with the PD drugs in unexpected ways [57]. This evidence concerns the gene SLC18A2 and Parkinson disease.